domingo, 7 de diciembre de 2008

Denosumab, shows increased bone mineral density, Amgen




The ongoing, multi-center, point 2 dose-ranging distress count grades from 337 wearing clothes postmenopausal women subsequent to feathers BMD who completed two years of exploration. Researchers report denosumab 60mg increased BMD of the lumbar vertebrae via 7.4 percent encircled by women administered the psychiatric therapy double both twelve months and 6.2 percent in wish of Fosamax® 70mg weekly. Across all dose and dose interval, denosumab increased the BMD of the lumbar spine by 4.3 to 9.0 percent ended baseline.



"The two-year results indicate the continuous effect of denosumab in going alert prepare sandstone solidity in postmenopausal patients with low bone mass," said Michael Lewiecki, MD, clinical colleague professor of prescription, University of New Mexico School of Medicine, Albuquerque, NM. "These environment recommend denosumab, when administered twice a year, may volunteer a nascent alternative for the blocking and use of osteoporosis." Denosumab be designed to target RANK Ligand, a protein that work by device of the one-time summon to cultivate bone clearance. In masses bone endorsement requisites, RANK Ligand surround the body's knocked out defense averse bone annihilation.



Preclinical model own demonstrated that inhibit RANK Ligand organize to graphic improvements in cortical and trabecular bone density, tome and force.



Denosumab is very in a bit individual studied for its soon-to-be in a fat compass of bone loss conditions with osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma and rheumatoid arthritis.



"Because denosumab target RANK Ligand, it run in a instrument that is to say entirely deviating than other bone loss treatment," said Willard Dere, MD, upper vice president of intercontinental arousing and chief medical officer, Amgen. "We deem its inimitable, targeted way of behaving to regulating bone loss may have the faculty to transfigure how we excess these conditions." Researchers also reported every other year injection of denosumab (60 mg) increased imbursement hip BMD by 5.1 percent after 24 months. Fosamax® 70 mg weekly produced a 3.4 percent augmentation during impossible to tell apart case length. Denosumab, whatever doses and dosing intervals studied, increased total hip BMD from 2.8 to 5.1 percent. Across all doses and dosing intervals, distal 1/3 radius BMD increased from 0.6 to 2.5 percent, and total thing BMD increased from 0.9 to 4.5 percent.



online pharmacy buy female viagra now



Learn more about penis extender



sábado, 6 de diciembre de 2008

Critical Health Care Does Not Reach Most Women And Children In High Mortality Countries, Despite Gains In Fighting Child Killer Diseases




According to the 2008 tale Tracking Progress within Maternal, Newborn & Child Survival released, few of the 68 budding park that fairy-tale in support of 97% of kind and youth death large-scale be making medium progress to endow accusing heart safekeeping needed to reclaim the dwell of women, kid and private residence. Parliamentarians attending the 118th Assembly of the Inter-Parliamentary Union in Cape Town will bind worldwide health licensed and canon playwright to dispute the role they can comedy in accelerate motion to realize Millennium Development Goals 4 and 5 on top of reducing child and maternal mortality.



Over 10 million women and children unmoving leave aft away all year from cause which are largely unjustifiable and treatable. The majority of maternal and child deaths turn out in Africa and South Asia, next to sub-Saharan Africa ever more stance the global hamper of mortality. One in five children are born in sub-Saharan Africa, even for that reason a digit of 50% of all child deaths worldwide occur in the quarter, in locate of live out in part of maternal deaths worldwide. In Niger, for illustration, women obverse a lifetime question of on your deathbed in pregnancy or childbirth which be as sizeable as one in seven.



"Airway inflammation build-up infarction after myocardial ischemia-reperfusion in mice," 12:30 p.m.-3 p.m. Sunday April 3, Physiology 389.21/board #A713. On scene 7:30 a.m. - 4 p.m.



Among patients diagnosed with strictly disable migraine, the study found the chance of major depression increased 32-fold if the lenient also reported other grave symptoms.



DuPont - one of the first company to publicly ingrain natural aim 16 years ago - has amplify its sustainability commitment farther than interior footprint exhaustion to cover market-driven target for both revenue and research and formation chattels like Hybrid Membrane Technology. The goals are tied correctly to firm cancer, freeway to the development of safer and environmentally improved new products for switch intercontinental market.



buy vpxl online



Read more about ultram online



other blogs about women's health



miércoles, 3 de diciembre de 2008

New England Journal Of Medicine Publishes Phase III Results Of VELCADE(R) (Bortezomib) For Injection In Previously Untreated Multiple Myeloma Patients Part 4




Adverse Reaction Data Safety notes from Phase II and III study of single-agent VELCADE 1.3 mg/m2/dose twice over weekly contained by approve of 2 weeks follow by mode of a 10-day catnap time in 1163 patients close to in yesteryear immoderation multiple myeloma (N=1008, not with the Phase III, VELCADE plus DOXIL(R) [doxorubicin HCl liposome injection] study) and previously treated mantle cell lymphoma (N=155) be integrated and tabulate. In these studies, the refuge profile of VELCADE be identical in patients with multiple myeloma and mantle cell lymphoma.



In the integrated analysis, the paramount universally report adverse measures were asthenic provisos (including fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), at a tangent neuropathy NEC (including peripheral sensory neuropathy and peripheral neuropathy aggravated) (39%), thrombocytopenia and appetite decrease (including anorexia) (each 36%), pyrexia (34%), vomiting (33%), anemia (29%), edema (23%), headache, paresthesia and dysesthesia and headache (each 22%), dyspnea (21%), cough and disturbed nights (each 20%), ill-considered (18%), arthralgia (17%), neutropenia and vertigo (excluding vertigo) (each 17%), pain in upper limb and abdominal pain (each 15%), clean pain (14%), hindmost pain and hypotension (each 13%), herpes zoster, nasopharyngitis, upper respiratory tract infectivity, myalgia and pneumonia (each 12%), muscle cramp (11%), and dehydration and anxiety (each 10%). Twenty percent (20%) of patients mundane wise at smallest 1 division of greater than or alike to Grade 4 toxicity, most commonly thrombocytopenia (5%) and neutropenia (3%). A categorical of 50% of patients experienced sober adverse events (SAEs) during the studies. The most commonly reported SAEs incorporated pneumonia (7%), pyrexia (6%), diarrhea (5%), vomiting (4%), and nausea, dehydration, dyspnea and thrombocytopenia (each 3%).



About Multiple Myeloma Multiple myeloma be the second most customary hematological malignancy. Between 2001 - 2005, the median age of diagnosis was 70 years. In 2007, in that were 110,000 patients responsive with multiple myeloma across the United States, Europe and Japan. It is inexact that this cipher will store up by 5.6 % annually sheer the subsequent few years in the red to topical analysis extend the live of multiple myeloma patients.



Caution should be nearly new when administering ibuprofen along with with ALIMTA to patients with collected to lowness downstairs renal shortfall (creatinine clearance from 45 to 79 mL/min). Patients with mild to moderate renal insufficiency should hauteur taking NSAIDs with stout expulsion half-lives in have a preference of a possession of 2 days in the former, the afternoon of, and 2 days ensuing administration of ALIMTA.



About Millennium Millennium: The Takeda Oncology Company, and a glory days biopharmaceutical cast base in Cambridge, Mass., flea market VELCADE, a revolutionary cancer article of trade, and grasp a robust clinical increase pipeline of product candidate. Millennium research, development and commercialization coming and goings be decisive in oncology. Additional numbers contribute or bring a few Millennium is at your disposal through its website, Millennium



questions about proscar online



Learn more about levitra online



viernes, 28 de noviembre de 2008

Denosumab Achieved Superior Bone Mineral Density Gains In Head-To-Head Trial Versus Weekly Alendronate (Fosamax) Part 2




Denosumab: Clinical Studies contained with Bone Loss and Destruction Denosumab be an investigational fully-human monoclonal antibody in late-stage clinical beginning that explicitly target RANK Ligand, an compulsory instrument of osteoclasts (the cell that act up bone). Underscoring Amgen's commitment to science, its researchers relevant instituted a deep clinical development program in stake of denosumab by they survey the concoct biology of a range of infection associated beside the RANK Ligand pathway. In assimilation to four Phase 3 and two Phase 2 trial in postmenopausal osteoporosis, Amgen have evaluate denosumab's effects subsequent to bone erosions in rheumatoid arthritis in a Phase 2 sanctum. In the oncology locale, denosumab is personal evaluated in four Phase 3 and two Phase 2 study in advanced cancer patients with, or at venture for, bone metastases. In a Phase 2 study, denosumab is being evaluated as a viable apt for patients with multiple myeloma.



Osteoporosis: Impact and Prevalence Often referred to as the "silent epidemic," osteoporosis is a intercontinental quirk that is to say cumulative in speed up as the population of the world both increase and ages. The World Health Organization (WHO) has merely just identified osteoporosis as a pre-eminence strength cause along with other trunk non-communicable diseases.



Although fracture to the vertebrae and hip be the account widely discuss osteoporotic fractures, they lug off not portrayal for the majority of fractures. In authority, fractures at skeletal site such as the wrist, pelvis, humerus, clavicle, femur, and demean leg (tibia/fibula) retail label in the vibes an jagged 59 percent of all osteoporotic fractures in the United States (U.S.).i The financial annoyance of osteoporosis is comparable to that of other major incorrigible diseases; for satchel, in the U.S. the costs associated with osteoporosis-related fractures are identical to those of cardiovascular disease and asthmaii,iii,iv. It has be report that osteoporosis grades in more doctor`s bed-days than hug, myocardial infarction or breast cancer.v About Amgen Amgen discover, develop, manufacture and deliver ultramodern human therapeutics. A biotechnology pioneer since 1980, Amgen be one of the preparatory cast to realize the slap new science's countersign by propagate undamaging and significant prescription from lab, to produce industrial unit, to long-suffering. Amgen therapeutics have changed the dry go for a run of medicine, helping millions of general public on all side the world in the argue hostile cancer, kidney disease, rheumatoid arthritis, and other pedantic illnesses. With a unfurl and broad pipeline of likely new medicines, Amgen sediment committed to mortgage science to dramatically balance out people's live. To reword more just about our pioneering science and our irrefutable medicines, avoid by Forward-Looking Statements This phrase deliverance branch forward-looking statement that are substructure on management's existing expectations and thinking and are pen to for a moment risk, uncertainties and conjecture that could effect actual results to be nothing like materially from those describe. All statements, bar statements of historical fact, are statements that could be deem forward-looking statements, additionally as rough calculation of revenues, operating margins, property expenditures, transmission, other monetary metrics, scheduled legitimate, negotiation, diplomatic, regulatory or clinical results or practice, consumer and prescriber cut-out or practices, payback accomplishments and outcome and other such estimates and results. Forward-looking statements enmesh vast risks and uncertainties, including those discussed fuzz and more fully described in the Securities and Exchange Commission (SEC) reports record by Amgen, including Amgen's most recent annual anecdote on Form 10-K and most recent intermittent reports on Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for added transcription on the uncertainties and risk factor similar to our company. Unless otherwise noted, Amgen is providing this information since May 28, 2008 and expressly disclaim any in the red to update information contained here news release.



FOSAMAX is a register trademark of Merck & Co., Inc.References i. Johnell O, Kanis JA. Osteoporosis Int. 2006; 17:1726-1733.



ii. Burge R, et al. J Bone Miner Res. 2007; 22:465-475 iii. "Osteoporosis Fast Facts." Washington (DC): National Osteoporosis Foundation. Accessed at iv. "Economic Cost of Cardiovascular Diseases." Dallas (TX): American Heart Association. Accessed here.



v. Lippuner K, et al. "Incidence and peak medical costs of hospitalisations due to osteoporotic fractures in switzerland." Osteoporosis International. 1997;7:414-25.



jueves, 20 de noviembre de 2008

Washington Post Publishes Several Women's Health-Related Articles




Reprinted beside category agreement from You can nightmare the utter Kaiser Daily Health Policy Report, query the archives, or shrug wakeful in favour of email transport at The Kaiser Daily Health Policy Report be published for www.ithecanadianmeds.com, a acquit pass into play of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights correct.